These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17785426)

  • 1. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse.
    Zhang Y; Wang H; Unadkat JD; Mao Q
    Drug Metab Dispos; 2007 Dec; 35(12):2154-8. PubMed ID: 17785426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pregnancy on nitrofurantoin disposition in mice.
    Zhang Y; Zhou L; Unadkat JD; Mao Q
    J Pharm Sci; 2009 Nov; 98(11):4306-15. PubMed ID: 19422048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study.
    Zhou L; Naraharisetti SB; Wang H; Unadkat JD; Hebert MF; Mao Q
    Mol Pharmacol; 2008 Mar; 73(3):949-59. PubMed ID: 18079276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
    Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.
    Merino G; Perez M; Real R; Egido E; Prieto JG; Alvarez AI
    Pharm Res; 2010 Oct; 27(10):2098-105. PubMed ID: 20607366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
    Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
    Jonker JW; Smit JW; Brinkhuis RF; Maliepaard M; Beijnen JH; Schellens JH; Schinkel AH
    J Natl Cancer Inst; 2000 Oct; 92(20):1651-6. PubMed ID: 11036110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid regulation of placental breast cancer resistance protein (Bcrp1) in the mouse.
    Petropoulos S; Gibb W; Matthews SG
    Reprod Sci; 2011 Jul; 18(7):631-9. PubMed ID: 21602547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
    de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
    Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP.
    de Vries NA; Buckle T; Zhao J; Beijnen JH; Schellens JH; van Tellingen O
    Invest New Drugs; 2012 Apr; 30(2):443-9. PubMed ID: 20963470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone.
    Kalabis GM; Petropoulos S; Gibb W; Matthews SG
    Placenta; 2007 Oct; 28(10):1073-81. PubMed ID: 17524480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse.
    Giri N; Shaik N; Pan G; Terasaki T; Mukai C; Kitagaki S; Miyakoshi N; Elmquist WF
    Drug Metab Dispos; 2008 Aug; 36(8):1476-84. PubMed ID: 18443033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and Fetal Exposure to (-)-Δ
    Chen X; Unadkat JD; Mao Q
    Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2.
    Wang X; Morris ME
    Drug Metab Dispos; 2007 Feb; 35(2):268-74. PubMed ID: 17093006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice.
    Kawase A; Matsumoto Y; Hadano M; Ishii Y; Iwaki M
    J Pharm Pharm Sci; 2009; 12(2):150-63. PubMed ID: 19732493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat.
    Cygalova L; Ceckova M; Pavek P; Staud F
    Toxicol Lett; 2008 May; 178(3):176-80. PubMed ID: 18450391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
    Feinshtein V; Erez O; Ben-Zvi Z; Eshkoli T; Sheizaf B; Sheiner E; Holcberg G
    Am J Obstet Gynecol; 2013 Dec; 209(6):573.e1-573.e15. PubMed ID: 23933222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors.
    Wang H; Wu X; Hudkins K; Mikheev A; Zhang H; Gupta A; Unadkat JD; Mao Q
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1295-304. PubMed ID: 17082346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
    Merino G; Alvarez AI; Pulido MM; Molina AJ; Schinkel AH; Prieto JG
    Drug Metab Dispos; 2006 Apr; 34(4):690-5. PubMed ID: 16434544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.